Pricing Log in Create free account

Biohaven Ltd. (BHVN) vs Xencor, Inc. (XNCR)

Biohaven Ltd. and Xencor, Inc. are both Biotechnology companies. Biohaven Ltd. and Xencor, Inc. are of similar size ($1.8B and $1.7B). Biohaven Ltd. grew revenue faster over the last twelve months: 425.2% against −28.6%. Biohaven Ltd. has the higher net margin (0.00% vs −155.6%) and the lower return on invested capital (−9,245.4% vs −288.7%). Across the 17 metrics below, Xencor, Inc. leads on 10 and Biohaven Ltd. on 7.

Valuation

Metric BHVN XNCR Biotechnology median
P/E n/m n/m 8.50
P/S 1.63 16.58 9.71
P/B 132.86 3.46 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 1.62 13.38 9.21
Earnings yield (43.04%) (9.46%) (33.15%)
Free cash flow yield (32.74%) (12.02%) (25.50%)

Profitability

Metric BHVN XNCR Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (205.84%) 0.00%
Net margin 0.00% (155.59%) 0.00%
Free cash flow margin 0.00% (198.42%) 0.00%
Return on equity (799.46%) (29.07%) (56.36%)
Return on assets (127.41%) (20.36%) (48.04%)
Return on invested capital (9,245.36%) (288.71%) 0.00%

Growth

Metric BHVN XNCR Biotechnology median
Revenue growth (TTM) 425.20% (28.56%) 6.02%
EPS growth (last fiscal year) 26.08% 65.36% 30.26%
Revenue growth, 5-year CAGR — 0.47% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BHVN XNCR Biotechnology median
Debt to equity 21.23 0.00 0.00
Current ratio 4.73 6.39 4.72
Net debt to EBITDA 0.11 2.51 0.96

Dividend

Metric BHVN XNCR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BHVN XNCR Biotechnology median
Market cap 1.73b 1.78b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack